Aclaris Therapeutics (ACRS) Goodwill & Intangibles (2017 - 2023)
Aclaris Therapeutics (ACRS) recorded quarterly Goodwill & Intangibles of $269000.0 in Q4 2023, down 96.11% quarter-over-quarter from $6.9 million in Q3 2023, and down 96.36% on a YoY basis from $7.4 million in Q4 2022.
Aclaris Therapeutics (ACRS) Goodwill & Intangibles (2017 - 2023) Analysis & Trends
Aclaris Therapeutics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $269000.0 for Q4 2023.
- In Q4 2023, Goodwill & Intangibles fell 96.36% year-over-year to $269000.0; the TTM figure through Dec 2023 stood at $269000.0 (down 96.36% YoY), while the FY2023 annual figure was $269000.0, down 96.36% from the prior year.
- Goodwill & Intangibles was $269000.0 for Q4 2023 at Aclaris Therapeutics, down from $6.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $92.3 million in Q1 2019 to a low of $269000.0 in Q4 2023.
- Historically, Goodwill & Intangibles has averaged $15.0 million across 5 years, with a median of $7.1 million in 2020.
- The sharpest annual moves came in 2019 and 2020: Goodwill & Intangibles sank 97.09% in 2019, then soared 851.0% in 2020.
- A 5-year view of Goodwill & Intangibles shows it stood at $25.9 million in 2019, then sank by 72.48% to $7.1 million in 2020, then climbed by 3.61% to $7.4 million in 2021, then changed by 0.0% to $7.4 million in 2022, then slumped by 96.36% to $269000.0 in 2023.
- The last three Goodwill & Intangibles figures came in at $269000.0 (Q4 2023), $6.9 million (Q3 2023), and $6.9 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 6.92 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 7.38 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 7.01 Mn |
| Mar 31, 2022 | 7.03 Mn |
| Dec 31, 2021 | 7.38 Mn |
| Sep 30, 2021 | 7.38 Mn |
| Jun 30, 2021 | 7.09 Mn |
| Mar 31, 2021 | 7.11 Mn |
| Dec 31, 2020 | 7.12 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 7.38 Mn |
| Mar 31, 2020 | 7.18 Mn |
| Dec 31, 2019 | 25.88 Mn |
| Sep 30, 2019 | 751,000.00 |
| Jun 30, 2019 | 73.80 Mn |
| Mar 31, 2019 | 92.30 Mn |